This article is more than 5 years old. Information may no longer be current.
Weill Cornell appoints director
Click Here to Manage Email Alerts
Lewis C. Cantley
Lewis C. Cantley, PhD, has been named director of the Cancer Center at Weill Cornell Medical College and New York-Presbyterian Hospital.
“We are honored and delighted to have Dr. Cantley, a pioneering researcher in the field of cancer, join us to lead the new Cancer Center,” Laurie H. Glimcher, MD, the Stephen and Suzanne Weill Dean of Weill Cornell Medical College and provost for medical affairs at Cornell University, said in a press release. “Multidisciplinary translational research is the future of biomedicine. There will be no barriers between our clinicians, translational researchers and basic scientists, whose close collaboration across disciplines and institutions will lead to new discoveries and cancer therapies — transforming cancer patient care and ultimately finding cures.”
The newly created center will establish a vast infrastructure that provides research space, resources and access to the latest state-of-the-art technologies for basic, clinical and translational cancer research. It also will offer support for initiating and conducting novel clinical trials. It will have a centralized cancer tumor tissue bank, patient database and a system for rapidly evaluating each patient’s cancer tumor for its genetic profile.
“We are on the brink of an evolution in cancer research and patient care that will dramatically change how our patients are diagnosed and how their diseases are managed,” Cantley, the William Bosworth Castle Chair in Medicine and professor of systems biology at Harvard, and director of the Cancer Center and chief of the Division of Signal Transduction at Beth Israel Deaconess Medical Center, said in a press release. “I look forward to leading the new cancer center at Weill Cornell Medical College and New York-Presbyterian and the beginning of the next revolution in cancer care with unparalleled progress in discovery research.”